Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration
      Google Scholar   
Citation:
Annals of Oncology vol 28 (suppl_5) v605-v649
Meeting Instance:
ESMO 2017
Year:
2017
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Comprehensive
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2805  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180835, U10CA180882, U10CA180888, INCA, PHRC2009, EME 09/800/34, HTA 14/140/84, CRUK C1348/A15960, JFMC  
Corr. Author:
 
Authors:
                                       
Networks:
CORA, LAPS-MA036, LAPS-MN026   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80702
Phases:
3
Keywords: